ATXS Annual SG&A
$25.70 M
+$6.46 M+33.60%
31 December 2023
Summary:
As of January 23, 2025, ATXS annual selling, general & administrative expenses is $25.70 million, with the most recent change of +$6.46 million (+33.60%) on December 31, 2023. During the last 3 years, it has risen by +$13.86 million (+117.00%). ATXS annual SG&A is now at all-time high.ATXS Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ATXS Quarterly SG&A
$8.50 M
+$410.00 K+5.07%
30 September 2024
Summary:
As of January 23, 2025, ATXS quarterly selling, general & administrative expenses is $8.50 million, with the most recent change of +$410.00 thousand (+5.07%) on September 30, 2024. Over the past year, it has increased by +$1.61 million (+23.28%). ATXS quarterly SG&A is now at all-time high.ATXS Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ATXS TTM SG&A
-$2.45 B
-$100.04 M-4.25%
30 September 2024
Summary:
As of January 23, 2025, ATXS TTM selling, general & administrative expenses is -$2.45 billion, with the most recent change of -$100.04 million (-4.25%) on September 30, 2024. Over the past year, it has dropped by -$2.48 billion (-10740.65%). ATXS TTM SG&A is now -3156.56% below its all-time high of $32.35 million, reached on September 30, 2024.ATXS TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ATXS Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +33.6% | +23.3% | -10000.0% |
| 3 y3 years | +117.0% | +23.3% | -10000.0% |
| 5 y5 years | +175.5% | +23.3% | -10000.0% |
ATXS Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +73.6% | at high | +122.9% | -38.6% | at low |
| 5 y | 5-year | at high | +193.1% | at high | +242.3% | -187.3% | at low |
| alltime | all time | at high | +523.1% | at high | +519.4% | -3156.6% | at low |
Astria Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $8.50 M(+5.1%) | $32.35 M(+5.2%) |
| June 2024 | - | $8.09 M(-3.9%) | $30.75 M(+7.3%) |
| Mar 2024 | - | $8.42 M(+14.9%) | $28.67 M(+11.5%) |
| Dec 2023 | $25.70 M(+33.6%) | $7.33 M(+6.3%) | $25.70 M(+11.4%) |
| Sept 2023 | - | $6.90 M(+14.7%) | $23.07 M(+10.6%) |
| June 2023 | - | $6.01 M(+10.1%) | $20.86 M(+6.0%) |
| Mar 2023 | - | $5.46 M(+16.2%) | $19.68 M(+2.3%) |
| Dec 2022 | $19.24 M(+29.9%) | $4.70 M(+0.2%) | $19.24 M(+4.8%) |
| Sept 2022 | - | $4.69 M(-3.0%) | $18.36 M(+3.3%) |
| June 2022 | - | $4.83 M(-3.7%) | $17.78 M(+4.9%) |
| Mar 2022 | - | $5.02 M(+31.6%) | $16.95 M(+14.4%) |
| Dec 2021 | $14.81 M(+25.0%) | $3.81 M(-7.2%) | $14.81 M(+4.1%) |
| Sept 2021 | - | $4.11 M(+2.5%) | $14.23 M(+8.0%) |
| June 2021 | - | $4.01 M(+39.2%) | $13.18 M(+10.1%) |
| Mar 2021 | - | $2.88 M(-10.9%) | $11.97 M(+1.1%) |
| Dec 2020 | $11.85 M(+35.0%) | $3.23 M(+5.8%) | $11.85 M(+6.7%) |
| Sept 2020 | - | $3.06 M(+9.1%) | $11.10 M(+10.7%) |
| June 2020 | - | $2.80 M(+1.8%) | $10.03 M(+6.8%) |
| Mar 2020 | - | $2.75 M(+10.8%) | $9.39 M(+7.0%) |
| Dec 2019 | $8.77 M | $2.48 M(+25.1%) | $8.77 M(+0.6%) |
| Sept 2019 | - | $1.99 M(-8.3%) | $8.72 M(-1.4%) |
| June 2019 | - | $2.17 M(+1.3%) | $8.84 M(-2.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | $2.14 M(-12.0%) | $9.07 M(-2.7%) |
| Dec 2018 | $9.33 M(+4.7%) | $2.43 M(+15.1%) | $9.33 M(+8.2%) |
| Sept 2018 | - | $2.11 M(-11.9%) | $8.62 M(-3.5%) |
| June 2018 | - | $2.40 M(+0.2%) | $8.94 M(-0.0%) |
| Mar 2018 | - | $2.39 M(+38.8%) | $8.94 M(+0.3%) |
| Dec 2017 | $8.91 M(-11.8%) | $1.72 M(-29.0%) | $8.91 M(-7.2%) |
| Sept 2017 | - | $2.43 M(+1.1%) | $9.60 M(+0.8%) |
| June 2017 | - | $2.40 M(+1.6%) | $9.52 M(-1.8%) |
| Mar 2017 | - | $2.36 M(-2.1%) | $9.70 M(-4.0%) |
| Dec 2016 | $10.11 M(+17.1%) | $2.41 M(+2.8%) | $10.11 M(-2.4%) |
| Sept 2016 | - | $2.35 M(-9.0%) | $10.36 M(-0.4%) |
| June 2016 | - | $2.58 M(-6.9%) | $10.40 M(+7.7%) |
| Mar 2016 | - | $2.77 M(+4.0%) | $9.65 M(+11.9%) |
| Dec 2015 | $8.63 M(+43.9%) | $2.66 M(+11.5%) | $8.63 M(+14.8%) |
| Sept 2015 | - | $2.39 M(+30.3%) | $7.52 M(+14.7%) |
| June 2015 | - | $1.83 M(+5.1%) | $6.56 M(+3.0%) |
| Mar 2015 | - | $1.74 M(+12.4%) | $6.37 M(+6.2%) |
| Dec 2014 | $6.00 M(+45.3%) | $1.55 M(+8.8%) | $5.99 M(+34.9%) |
| Sept 2014 | - | $1.43 M(-13.1%) | $4.44 M(+47.3%) |
| June 2014 | - | $1.64 M(+19.6%) | $3.02 M(+119.6%) |
| Mar 2014 | - | $1.37 M | $1.37 M |
| Dec 2013 | $4.13 M | - | - |
FAQ
- What is Astria Therapeutics annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Astria Therapeutics?
- What is Astria Therapeutics annual SG&A year-on-year change?
- What is Astria Therapeutics quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Astria Therapeutics?
- What is Astria Therapeutics quarterly SG&A year-on-year change?
- What is Astria Therapeutics TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Astria Therapeutics?
- What is Astria Therapeutics TTM SG&A year-on-year change?
What is Astria Therapeutics annual selling, general & administrative expenses?
The current annual SG&A of ATXS is $25.70 M
What is the all time high annual SG&A for Astria Therapeutics?
Astria Therapeutics all-time high annual selling, general & administrative expenses is $25.70 M
What is Astria Therapeutics annual SG&A year-on-year change?
Over the past year, ATXS annual selling, general & administrative expenses has changed by +$6.46 M (+33.60%)
What is Astria Therapeutics quarterly selling, general & administrative expenses?
The current quarterly SG&A of ATXS is $8.50 M
What is the all time high quarterly SG&A for Astria Therapeutics?
Astria Therapeutics all-time high quarterly selling, general & administrative expenses is $8.50 M
What is Astria Therapeutics quarterly SG&A year-on-year change?
Over the past year, ATXS quarterly selling, general & administrative expenses has changed by +$1.61 M (+23.28%)
What is Astria Therapeutics TTM selling, general & administrative expenses?
The current TTM SG&A of ATXS is -$2.45 B
What is the all time high TTM SG&A for Astria Therapeutics?
Astria Therapeutics all-time high TTM selling, general & administrative expenses is $32.35 M
What is Astria Therapeutics TTM SG&A year-on-year change?
Over the past year, ATXS TTM selling, general & administrative expenses has changed by -$2.48 B (-10740.65%)